Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Nava Therapeutics Launches with $89M to Advance Extrahepatic LNP Delivery for In Vivo CAR-T and Kidney Gene Editing
Date 24 July 2026

Nava Therapeutics Launches with $89M to Advance Extrahepatic LNP Delivery for In Vivo CAR-T and Kidney Gene Editing

Nava Therapeutics has launched with $89 million in funding to advance a lipid nanoparticle platform intended to deliver RNA medicines beyond the liver, with initial programs significantly focused on i...

FDA Writes to Infant Formula Manufacturers Urging Them to Tighten Supplier Oversight
Date 21 July 2026

FDA Writes to Infant Formula Manufacturers Urging Them to Tighten Supplier Oversight

The US Food and Drug Administration (FDA) has advised infant formula producers to tighten supplier oversight after botulism outbursts and a contaminated ingredient triggered recalls in multiple market...

Cytovance Biologics Expands Process Development Services with Perfusion Capabilities
Date 22 July 2026

Cytovance Biologics Expands Process Development Services with Perfusion Capabilities

Cytovance Biologics, an important US-based contract development and manufacturing organization (CDMO) helping the pharmaceutical organization, announced the expansion of its upstream process advanceme...

CDSCO Approves India-Developed Synthetic Cannabidiol Oral Solution for Anxiety Disorders
Date 20 July 2026

CDSCO Approves India-Developed Synthetic Cannabidiol Oral Solution for Anxiety Disorders

Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted government support to its collaboration partner, Zenara Pharma, to produce a Syntheti...

Evonik invests US$100 million to Upgrade its U.S. Drug Substance Contract Manufacturing Site
Date 20 July 2026

Evonik invests US$100 million to Upgrade its U.S. Drug Substance Contract Manufacturing Site

Evonik is making a noteworthy investment to support production abilities at its Lafayette, Indiana, facility. After completing the next five years, the organization will spend US$100 million to modern...

Givaudan announces strategic collaboration with Microcaps
Date 22 July 2026

Givaudan announces strategic collaboration with Microcaps

Givaudan, the worldwide leader in fragrance and beauty, announced an equity spending and strategic partnering with the Swiss organization Microcaps AG to strengthen its encapsulation capabilities, rei...

UMN researchers create the world’s first synthetic cell
Date 16 July 2026

UMN researchers create the world’s first synthetic cell

SpudCell is the first artificial cell that can feed, grow, and achieve an entire life cycle. It is made entirely of non-living chemical mechanisms, marking a significant step for synthetic biology, ba...

Inside Therapeutics Meiwafosis: bringing TAMARA to Japan
Date 20 July 2026

Inside Therapeutics Meiwafosis: bringing TAMARA to Japan

Inside Therapeutics partners with Meiwafosis Co., Ltd. to bring microfluidic nanoparticle formulation technology to scientists in the country, backed by a distributor who knows the local research land...

Biocon Strengthens Confidence in Yesafili with New Clinical Evidence
Date 21 July 2026

Biocon Strengthens Confidence in Yesafili with New Clinical Evidence

Peer-Reviewed Studies Confirm Strong Clinical Performance Biocon announced the publication of important clinical data supporting the effectiveness of Yesafili, its biosimilar version of Eylea (aflibe...

GSK Velu Charts IPO Path for Four Healthcare Companies in Major Growth Push
Date 15 July 2026

GSK Velu Charts IPO Path for Four Healthcare Companies in Major Growth Push

Healthcare Entrepreneur Plans a New Phase of Expansion On 12th July 2026, Indian healthcare entrepreneur GSK Velu is preparing for a major milestone in his business journey by planning to list four o...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.